Hepatitis G virus (HGV) and GB virus C (GBV-C) are two newly discovere
d viral agents, different isolates of a positive-sense RNA virus that
represents a new genus of Flaviviridae, The purpose of this review is
to analyze new data that have recently been published on the epidemiol
ogy and associations between HCV and liver diseases such as posttransf
usion hepatitis, acute and chronic non-A-E hepatitis, fulminant hepati
tis, cryptogenic cirrhosis, and hepatocellular carcinoma, The role of
HGV in coinfection with other hepatitis viruses, the response to antiv
iral therapy, and the impact of HGV on liver transplantation are also
discussed, HCV is a transmissible blood-borne viral agent that frequen
tly occurs as a coinfection with other hepatitis viruses due to common
modes of transmission, The prevalence of HCV ranges from 0.9 to 10% a
mong blood donors throughout the world and is found in 1.7% of volunte
er blood donors in the United States, The majority of patients infecte
d with HCV by blood transfusion do not develop chronic hepatitis, but
hepatitis C viremia frequently persists without biochemical evidence o
f hepatitis. Serum HCV RNA has been found in 0 to 50% of patients with
fulminant hepatitis of unknown etiology and 14 to 36% of patients wit
h cryptogenic cirrhosis, The association between HCV and chronic non-A
-E hepatitis remains unclear, Although HGV appears to be a hepatotroph
ic virus, its role in independently causing acute and chronic liver di
seases remains uncertain.